Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy.

导出 LinkOut

翻译打印收藏纠错

作者： C,Lefebvre ^[1] ; E,Martin ^[2] ; L E L,Hendriks ^[3] ; R,Veillon ^[1] ; F,Puisset ^[4] ; L,Mezquita ^[5] ; R,Ferrara ^[5] ; M,Sabatier ^[4] ; T,Filleron ^[2] ; A-M C,Dingemans ^[3] ; B,Besse ^[5] ; C,Raherisson ^[1] ; J,Mazières ^[6]

作者单位： Department of Pneumology, University Hospital of Bordeaux, 33604 Pessac, France. ^[1] Biostatistics Unit, Institut Claudius Regaud, IUCT-O, Toulouse, France. ^[2] Department of Pulmonology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands. ^[3] Pharmacy department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius-Regaud, Toulouse, France. ^[4] Institut d'Oncologie Thoracique, Institut Gustave Roussy, Villejuif, France. ^[5] Pulmonology Department, Toulouse University Hospital, Université Paul Sabatier, Toulouse, France. Electronic address: mazieres.j@chu-toulouse.fr. ^[6]

关键词 Chemotherapy Immune checkpoint inhibitors Non-small cell lung cancer Prognosis

主题词成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);化学疗法, 辅助(Chemotherapy, Adjuvant);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);法国(France);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);预后(Prognosis);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)

DOI 10.1016/j.resmer.2020.100788

PMID 32980653

发布时间 2021-09-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Respiratory medicine and research

2020年78卷

100788页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy.

Respiratory medicine and research

相似文献

Respiratory medicine and research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy.

Respiratory medicine and research

相似文献

Respiratory medicine and research

相关期刊

检索历史清除